May, Margaret T3; Hogg, Robert S4; Justice, Amy C4; Shepherd, Bryan E4; Costagliola, Dominique4; Ledergerber, Bruno4; Thiébaut, Rodolphe4; Gill, M John4; Kirk, Ole5; van Sighem, Ard4; Saag, Michael S4; Navarro, Gemma4; Sobrino-Vegas, Paz4; Lampe, Fiona4; Ingle, Suzanne4; Guest, Jodie L4; Crane, Heidi M4; D'Arminio Monforte, Antonella4; Vehreschild, Jörg J4; Sterne, Jonathan A C4
1 Department of Clinical Medicine, Department of Clinical Medicine, Faculty of Health and Medical Sciences, Københavns Universitet2 CHIP, Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, Københavns Universitet3 School of Social and Community Medicine, University of Bristol, Bristol, UK. firstname.lastname@example.org unknown5 Department of Clinical Medicine, Department of Clinical Medicine, Faculty of Health and Medical Sciences, Københavns Universitet
relation with patient and cohort characteristics
HIV cohort collaborations, which pool data from diverse patient cohorts, have provided key insights into outcomes of antiretroviral therapy (ART). However, the extent of, and reasons for, between-cohort heterogeneity in rates of AIDS and mortality are unclear.
International Journal of Epidemiology, 2012, Vol 41, Issue 6, p. 1807-20
Acquired Immunodeficiency Syndrome; Adolescent; Adult; Age Factors; Aged; Anti-Retroviral Agents; CD4 Lymphocyte Count; Europe; Female; HIV Infections; HIV Seropositivity; Humans; Male; Middle Aged; North America; Prognosis; Risk Factors; Sex Factors; Young Adult